RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Miami, FL · Orlando, FL · Tampa, FL · +9 more sites
Prostate Cancer clinical trials in Orlando, FL
16 recruiting prostate cancer studies with a site in Orlando, FL.
RecruitingNot applicableNCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Sponsor: Axonics, Inc.
Miami, FL · Orlando, FL · Oxford, FL · +20 more sites
RecruitingPhase 1 / Phase 2NCT07529717
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
Sponsor: AstraZeneca
Orlando, FL · +3 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Aventura, FL · Coral Gables, FL · Deerfield Beach, FL · +331 more sites
RecruitingPhase 1NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Sponsor: Genentech, Inc.
Orlando, FL · +4 more sites
RecruitingPhase 1 / Phase 2NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Sponsor: PMV Pharmaceuticals, Inc
Miami, FL · Orlando, FL · Port Charlotte, FL · +29 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Orlando, FL · Sarasota, FL · +57 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Miami, FL · Orlando, FL · +33 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
Miami, FL · Orlando, FL · Port Saint Lucie, FL · +19 more sites
RecruitingPhase 2NCT04038502
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Sponsor: VA Office of Research and Development
Bay Pines, FL · Orlando, FL · +16 more sites
RecruitingPhase 2NCT05011383
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Sponsor: VA Office of Research and Development
Gainesville, FL · Orlando, FL · +15 more sites
RecruitingPhase 1 / Phase 2NCT07192614
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Orlando, FL · Tampa, FL · +4 more sites
RecruitingPhase 1 / Phase 2NCT05785741
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Coral Gables, FL · Margate, FL · Orlando, FL · +12 more sites
RecruitingPhase 1NCT07181473
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Phrontline Biopharma
Orlando, FL · +2 more sites
RecruitingPhase 1NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Sponsor: Dren Bio
Orlando, FL · Sarasota, FL · +8 more sites
RecruitingPhase 1 / Phase 2NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Celebration, FL · Margate, FL · Orlando, FL · +25 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.